Results 151 to 160 of about 97,157 (255)

A Systematic Review of Adverse Childhood Experiences and Epigenetic Age Acceleration in Later Adult Life Measured With Second and Third‐Generation Epigenetic Clocks

American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, EarlyView.
ABSTRACT We examined the relationship between adverse childhood experiences (ACEs) and epigenetic age acceleration (EAA) in adulthood as measured by second and third generation epigenetic clocks by performing a systematic review of the literature. The electronic databases MEDLINE and EMBASE were searched on 17 July 2023.
Matthew Green, Laura Horsfall, Azam Saied   +2 more
wiley   +1 more source

Explainable multilingual and multimodal fake-news detection: toward robust and trustworthy AI for combating misinformation. [PDF]

Front Artif Intell
Jadhav R, Meshram V, Bhosle A, Patil K, Dash S, Jadhav S.   +5 more
europepmc   +1 more source

Anatomical Progression of Neuropathology in FTLD‐TDP Type C and Linkage to Annexin A11

Annals of Neurology, EarlyView.
Objective Frontotemporal lobar degenerations (FTLD)‐TDP type C (TDP‐C) is distinguished from other FTLD‐TDP subtypes by 3 unique features: (1) invariable onset in the anterior temporal lobe (ATL), (2) phosphorylated TDP‐43 (pTDP) neurites in cortex, and (3) colocalization of all pTDP deposits with annexin A11 (ANXA11).
Allegra Kawles, Caroline Nelson, Ivan Ayala, Elena Barbieri, Rudolph Castellani, Changiz Geula, Tamar Gefen, M. Marsel Mesulam   +7 more
wiley   +1 more source

Micro/Nanorobot for Drug Delivery—A Review of Material Selections

Advanced NanoBiomed Research, EarlyView.
This review explores material strategies for biomedical micro/nanorobots, emphasizing their roles in propulsion, navigation, drug delivery, and biodegradability. It highlights advancements in metallic, polymeric, and hybrid materials, while addressing clinical translation challenges such as toxicity, immune response, and manufacturability.
Xiaozhuo Wu, Bingyun Li, Malcolm Xing
wiley   +1 more source

Technobiological Pathways for High‐CO₂ Capture Using Micro‐/Macroalgae: Genetic Engineering, Process Automation, and Value‐Added Bioproducts

Asia-Pacific Journal of Chemical Engineering, EarlyView.
ABSTRACT Greenhouse gas (GHG) emissions have emerged as one of the most critical drivers of climate change; this is primarily due to high concentrations and long atmospheric life of carbon dioxide (CO2). For a significant amount of time, various biological processes such as microalgal cultivation, cyanobacterial systems, photosynthetic microorganisms ...
Sadhana Semwal, Harish Chandra Joshi
wiley   +1 more source

Shaping the Future of Healthcare: Ethical Clinical Challenges and Pathways to Trustworthy AI. [PDF]

J Clin Med
Goktas P, Grzybowski A.
europepmc   +1 more source

Physically Based Predictive Modelling of Archaeological Proxies Using Cropmarks

Archaeological Prospection, EarlyView.
ABSTRACT Cropmarks, as archaeological proxies, offer a valuable means of detecting buried sites through remote sensing. Yet, the scalability of such methods across varied archaeological contexts remains underexplored, and AI‐based modelling approaches are still in early stages.
Elias Gravanis, Athos Agapiou
wiley   +1 more source

Establishing and evaluating trustworthy AI: overview and research challenges. [PDF]

Front Big Data
Kowald D, Scher S, Pammer-Schindler V, Müllner P, Waxnegger K, Demelius L, Fessl A, Toller M, Mendoza Estrada IG, Šimić I, Sabol V, Trügler A, Veas E, Kern R, Nad T, Kopeinik S.   +15 more
europepmc   +1 more source

AI Ethics and Regulations: Ensuring Trustworthy AI

International Journal of Artificial Intelligence for Science (IJAI4S)
As Artificial Intelligence (AI) technologies become increasingly embedded in critical aspects of modern life—ranging from healthcare diagnostics and financial forecasting to autonomous vehicles, law enforcement, education, and national security—the urgency of addressing their ethical implications has grown exponentially.
openaire   +1 more source

Risk factors for relapse in ANCA‐associated vasculitis among patients with relapse after induction of remission with rituximab

Arthritis &Rheumatology, Accepted Article.
Objective To determine risk factors for relapse of ANCA‐associated vasculitis (AAV) after re‐induction of remission with rituximab and discontinuation of maintenance therapy. Methods This is a post‐hoc analysis of the RITAZAREM clinical trial. Patients 15 years or older with AAV and a positive test for anti‐proteinase‐3 (PR3‐) or anti‐myeloperoxidase ...
Ellen Romich, Joshua F. Baker, Thomas R. Riley IV, Ian Green, Rennie L. Rhee, Carol A. McAlear, Ulrich Specks, Rona M. Smith, David R. Jayne, Peter A. Merkel, for the RITAZAREM Investigators   +10 more
wiley   +1 more source